Shilpa Pharma, Inc., is a wholly owned subsidiary of Shilpa Medicare Limited, established in 1987 and HQ'd in Raichur, approx. 130 miles from Hyderabad. We bring 30+ years of experience in pharmaceutical R&D along with a large portfolio of innovative products across franchise areas. We have emerged as one of the largest manufacturers of oncology API and formulations in India and are a trusted supply chain partner for the development of small and large molecules, incl., vaccines, MAbs, fusion proteins and peptides, OTC medications as well as specialized segments such as polymers and performance materials. We have full-fledged in-house R&D laboratories and manufacturing facilities for API and formulation development of a range of oral and injectable dosage forms as well as novel drug delivery and extended release technologies such as oral dissolving films and transdermal systems. In biologics, we have end to end upstream and downstream capabilities for microbial and mammalian expression systems from clone development to cGMP cell banking to manufacturing (fill and finish).We are fully integrated covering early phase and late phase DS and DP development and cGMP manufacturing with approvals from global regulatory agencies such as USFDA, Health Canada, EMA, PMDA, KFDA, Cofepris, TGA, and others. This includes specialized solutions in AI/ML led drug discovery and flow chemistry where we leverage our expertise to offer tangible cost and time savings across early phase and late phase drug discovery and development.We have a range of oncology and non-oncology A/NDAs available for licensing and for these and for R&D partnerships for your clinical pipeline of small and large molecules, we welcome inquiries for development, long-term supply and distribution agreements.